Hemorrhagic Fever, Ebola
6 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Ad26.ZEBOV + MVA-BN-Filo for hemorrhagic fever, ebola | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ansuvimab for hemorrhagic fever, ebola | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ervebo® booster for hemorrhagic fever, ebola | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Inmazeb for hemorrhagic fever, ebola | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| RECOMBINANT ZAIRE EBOLAVIRUS KIKWIT-95 ENVELOPE GLYCOPROTEIN MODIFIED VESICULAR STOMATITIS VIRUS for hemorrhagic fever, ebola | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Zabdeno® booster for hemorrhagic fever, ebola | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |